Press Release Distribution
 

Members Login  |  Register  |  Why Join?   Subscribe to Newsletter Newsletter   RSS Feeds RSS Feeds

Video Releases    |    Pricing & Distribution Plans    |    Today's News    |    News By Category    |    News By Region    |    News By Date    |    Business Directory
All Press Releases for August 29, 2005 »
RSS Feeds RSS Feed     Print this news Printer Friendly     Email this news Email It    Create PDF PDF Version    Bookmark del.icio.us    Diggs



Cause of Primary Pulmonary Hypertension (PPH) still unknown but many link it to weight loss drugs
Fen-Phen, Redux, and Pondimin have been off the market for some time but doctors are still diagnosing patients with PPH after taking diet drugs years earlier. 
x-small text small text medium text large text


    /24-7PressRelease/ - ST. LOUIS, MISSOURI, August 29, 2005 - A leading law firm, in association with LawyersandSettlements.com, is keeping the public aware of the prolonged effects of diet drugs and their link to Primary Pulmonary Hypertension (PPH).

According to the American Heart Association, an estimated 500 to 1,000 new cases of PPH are diagnosed in the U.S. each year; most of these cases are women between ages 20 and 40. PPH is a rare and potentially life threatening lung disorder in which the blood pressure in the pulmonary artery of the heart rises far above normal levels for no apparent reason. This serious type of hypertension or high blood pressure is recognized when the average blood pressure is greater than 25 mm Hg at rest.

Physicians began diagnosing patients with PPH in the 1970s and have yet to identify a cause. Experts note that there is typically a delayed diagnosis for up to 10 years and have linked PPH with the use of appetite suppressants and weight loss drugs. Specifically, a study published in the New England Journal of Medicine (1996) found that the use of Fen Phen for three months or longer increased the risk of developing PPH by 23%.

Responding to reports of heart disease linked to Fen-Phen and other weight loss prescription drugs, the FDA recalled the popular diet drugs Redux (dexfenfluramine), Pondimin (fenfluramine) and Fen-Phen (fenfluramine and phentermine) in 1997. Before they were recalled, these appetite suppressants were taken by nearly six to seven million consumers worldwide. Mounting evidence and hundreds of consumer reports links Pondimin and Fen-Phen to Primary Pulmonary Hypertension, heart valve problems, and neurotoxicity of the brain.

The initial symptoms of PPH can include weakness, fatigue, shortness of breath, chest pain, dizzy spells, and fainting. Advanced symptoms of PPH, due to delayed diagnosis, can include bluish lips and skin, ankle and lower leg swelling, increased chest pain, and even death.

A St. Louis-based law firm is investigating whether the use of diet drugs is linked to PPH and is urging patients that have had been diagnosed with PPH to come forward. For more details about this product recall and potential class action lawsuit, visit
https://www.lawyersandsettlements.com/case/pph_class_action

About Online Legal Services Ltd (OLS) and http://www.lawyersandsettlements.com
OLS is a privately held internet marketing company that specializes in joint advertising campaigns for lawyers and law firms. Lawyersandsettlements.com offers a comprehensive website with up-to-date information on legal news, class action lawsuits, personal injury cases, settlement details, product recalls, and more. Consumers can complete free case evaluations and subscribe to free newsletters.


---
Press release service and press release distribution provided by http://www.24-7pressrelease.com


# # #


Read more Press Releases from Tracy Laxdal:
Other Press Release Headlines:


Press Release Service & Press Release Distribution News Supplied By 24-7PressRelease.com
Press Release Contact Information:
Tracy Laxdal
LawyersandSettlements.com

Marketing Manager
E-Mail: Email us Here
Website: Visit Our Website
Disclaimer:
If you have any questions regarding information in this press release, please contact the person listed in the contact module of this page. Please do not attempt to contact 24-7 Press Release. We are unable to assist you with any information regarding this release. 24-7 Press Release disclaims any content contained in this press release. Please see our complete Terms of Service disclaimer for more information.